NexImmune NEXI

$ 3.93 70.13%

Quarterly report 2024-Q2
added 08-07-2024

NexImmune Balance Sheet 2011-2024 | NEXI

Annual Balance Sheet NexImmune

	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-	-5.03 M	-9.13 M	-426 K	-	-	-	-	-	-	-
Long Term Debt	-	426 K	-	-	-	-	-	-	-	-	-	-	-
Long Term Debt Current	68.8 K	599 K	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	4.94 K	81.9 K	329 K	-	-	-	-	-	-	-
Total Current Liabilities	5.08 M	10.3 M	7.22 M	-	-	-	-	-	-	-	-	-	-
Total Liabilities	5.08 M	10.8 M	7.27 M	27.1 M	3.11 M	3.33 M	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-223 M	-190 M	-128 M	-	-47.7 M	-27.2 M	-	-	-	-	-	-	-
Total Assets	8.59 M	43.1 M	91 M	11.3 M	13.7 M	14.1 M	-	-	-	-	-	-	-
Cash and Cash Equivalents	3.2 M	34.6 M	30.3 M	5.1 M	-	-	-	-	-	-	-	-	-
Book Value	3.51 M	32.3 M	83.8 M	-15.8 M	10.6 M	10.8 M	-	-	-	-	-	-	-
Total Shareholders Equity	3.51 M	32.3 M	83.8 M	-69.4 M	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet NexImmune

	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	-	-	-	103 K	204 K	300 K	426 K	565 K	700 K	829 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	4.94 M	6.02 M	5.08 M	6.31 M	6.47 M	7.09 M	10.8 M	9.96 M	9.81 M	7.92 M	7.27 M	7.43 M	5.48 M	6.1 M	27.1 M	27.1 M	27.1 M	27.1 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-228 M	-226 M	-223 M	-217 M	-207 M	-200 M	-190 M	-173 M	-159 M	-143 M	-128 M	-112 M	-97.6 M	-85.4 M	-77.6 M	-77.6 M	-77.6 M	-77.6 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	5.86 M	8.99 M	8.59 M	14.6 M	23.5 M	30.7 M	43.1 M	57.7 M	65.7 M	78.3 M	91 M	105 M	115 M	127 M	11.3 M	11.3 M	11.3 M	11.3 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	2.42 M	4.45 M	3.2 M	9 M	16.3 M	22.4 M	34.6 M	46 M	40.7 M	24.6 M	30.3 M	37.3 M	63.9 M	118 M	5.03 M	5.03 M	5.03 M	5.03 M	9.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	921 K	2.97 M	3.51 M	8.25 M	17 M	23.6 M	32.3 M	47.7 M	55.9 M	70.4 M	83.8 M	97.1 M	110 M	120 M	-15.8 M	-15.8 M	-15.8 M	-15.8 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	696 K	2.74 M	3.51 M	8.25 M	17 M	23.6 M	32.3 M	47.7 M	55.9 M	70.4 M	83.8 M	97.1 M	110 M	120 M	-69.4 M	-69.4 M	-69.4 M	-69.4 M	-43 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency